BERND ARNOLD ET AL: "MHC Class-I Transgenic Mice", ANNUAL REVIEW OF IMMUNOLOGY, vol. 9, no. 1, 1 April 1991 (1991-04-01), pages 297-322, XP055052580, ISSN: 0732-0582, DOI: 10.1146/annurev.iy.09.040191.001501 (B1)

CHAMBERLAIN: "Tissue-specific and cell surface expression of human major histocompatibility complex class I heavy (HLA-B7) and light (beta 2-microglobulin) chain genes in transgenic mice", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 85, no. 20, 1 January 1988 (1988-01-01), page 7690, XP055052661, ISSN: 0027-8424 (B1)

GUESSOW D ET AL: "THE HUMAN BETA2-MICROGLOBULIN GENE PRIMARY STRUCTURE AND DEFINITION OF THE TRANSCRIPTIONAL UNIT", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 139, no. 9, 1 November 1987 (1987-11-01), pages 3132-3138, XP000995147, ISSN: 0022-1767 (B1)

KAPLAN B L F ET AL: "A new murine tumor model for studying HLA-A2-restricted anti-tumor immunity", CANCER LETTERS, NEW YORK, NY, US, vol. 224, no. 1, 16 June 2005 (2005-06-16) , pages 153-166, XP027608047, ISSN: 0304-3835 [retrieved on 2005-06-16] (B1)

LI J ET AL: "Mamu-A@?01/K<b> transgenic and MHC Class I knockout mice as a tool for HIV vaccine development", VIROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 387, no. 1, 25 April 2009 (2009-04-25), pages 16-28, XP026067221, ISSN: 0042-6822, DOI: 10.1016/J.VIROL.2009.01.041 [retrieved on 2009-02-27] (B1)

M. J. IRWIN: "Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 170, no. 4, 1 October 1989 (1989-10-01), pages 1091-1101, XP055052826, ISSN: 0022-1007, DOI: 10.1084/jem.170.4.1091 (B1)

WO-A2-2005/004592 (B1)

PASCOLO STEVE ET AL: "HLA-A2.1-restricted education and cytolytic activity of CD8+ T lymphocytes from beta-2 microglobulin (beta-2m) HLA-A2.1 monochain transgenic H-2D-b beta-2m double knockout mice", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 185, no. 12, 1 January 1997 (1997-01-01), pages 2043-2051, XP002469861, ISSN: 0022-1007, DOI: 10.1084/JEM.185.12.2043 (B1)

REN D ET AL: "Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta2m as a fusion protein in Escherichia coli", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, vol. 50, no. 2, 1 December 2006 (2006-12-01), pages 171-178, XP024908840, ISSN: 1046-5928, DOI: 10.1016/J.PEP.2006.08.001 [retrieved on 2006-12-01] (B1)

ULRICH KALINKE ET AL: "Strong xenogeneic HLA response in transgenic mice after introducing an [alpha]3 domain into HLA B27", NATURE, vol. 348, no. 6302, 13 December 1990 (1990-12-13), pages 642-644, XP055052576, ISSN: 0028-0836, DOI: 10.1038/348642a0 (B1)

VITIELLO A ET AL: "ANALYSIS OF THE HLA-RESTRICTED INFLUENZA-SPECIFIC CYTOTOXIC T LYMPHOCYTE RESPONSE IN TRANSGENIC MICE CARRYING A CHIMERIC HUMAN-MOUSE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 173, no. 4, 1 April 1991 (1991-04-01) , pages 1007-1015, XP000940536, ISSN: 0022-1007, DOI: 10.1084/JEM.173.4.1007 (B1)

WO-A1-03/006639 (B1)

NANCY L. SAMBERG ET AL: "The [alpha]3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulation", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 19, no. 12, 1 December 1989 (1989-12-01), pages 2349-2354, XP055424874, ISSN: 0014-2980, DOI: 10.1002/eji.1830191225 (B1)